Turning off the BCL-2 switch to prevent intestinal tumorigenesis
Turning off the BCL-2 switch to prevent intestinal tumorigenesis |
https://doi.org/10.18632/oncotarget.8757
Maartje van der Heijden,
Douglas J. Winton,
and Louis Vermeulen
|
28763-28764 |
Angiomotin stabilization by tankyrase inhibitors antagonizes constitutive TEAD-dependent transcription and proliferation of human tumor cells with Hippo pathway core component mutations
Angiomotin stabilization by tankyrase inhibitors antagonizes constitutive TEAD-dependent transcription and proliferation of human tumor cells with Hippo pathway core component mutations |
https://doi.org/10.18632/oncotarget.9117
Albino Troilo,
Erica K. Benson,
Davide Esposito,
Rachel-Ann A. Garibsingh,
E. Premkumar Reddy,
Sathish Kumar Mungamuri,
and Stuart A. Aaronson
|
28765-28782 |
Inflammatory and immune markers associated with physical frailty syndrome: findings from Singapore longitudinal aging studies
Inflammatory and immune markers associated with physical frailty syndrome: findings from Singapore longitudinal aging studies |
https://doi.org/10.18632/oncotarget.8939
Yanxia Lu,
Crystal Tze Ying Tan,
Ma Shwe Zin Nyunt,
Esther Wing Hei Mok,
Xavier Camous,
Hassen Kared,
Tamas Fulop,
Liang Feng,
Tze Pin Ng,
and Anis Larbi
|
28783-28795 |
MicroRNA-93 inhibits ischemia-reperfusion induced cardiomyocyte apoptosis by targeting PTEN
MicroRNA-93 inhibits ischemia-reperfusion induced cardiomyocyte apoptosis by targeting PTEN |
https://doi.org/10.18632/oncotarget.8941
Zun-Ping Ke,
Peng Xu,
Yan Shi,
and Ai-Mei Gao
|
28796-28805 |
Identification of the microRNA networks contributing to macrophage differentiation and function
Identification of the microRNA networks contributing to macrophage differentiation and function |
https://doi.org/10.18632/oncotarget.8933
Hong Zhou,
Jie Zhang,
Fiona Eyers,
Yang Xiang,
Cristan Herbert,
Hock, L. Tay,
Paul S. Foster,
and Ming Yang
|
28806-28820 |
Mitophagy acts as a safeguard mechanism against human vascular smooth muscle cell apoptosis induced by atherogenic lipids
Mitophagy acts as a safeguard mechanism against human vascular smooth muscle cell apoptosis induced by atherogenic lipids |
https://doi.org/10.18632/oncotarget.8936
Audrey Swiader,
Hripsime Nahapetyan,
Julien Faccini,
Romina D’Angelo,
Elodie Mucher,
Meyer Elbaz,
Patricia Boya,
and Cécile Vindis
|
28821-28835 |
Setdb1, a novel interactor of ΔNp63, is involved in breast tumorigenesis
Setdb1, a novel interactor of ΔNp63, is involved in breast tumorigenesis |
https://doi.org/10.18632/oncotarget.7089
Carla Regina,
Mirco Compagnone,
Angelo Peschiaroli,
AnnaMaria Lena,
Margherita Annicchiarico-Petruzzelli,
Maria Cristina Piro,
Gerry Melino,
and Eleonora Candi
|
28836-28848 |
The histone deacetylase inhibitor SAHA induces HSP60 nitration and its extracellular release by exosomal vesicles in human lung-derived carcinoma cells
The histone deacetylase inhibitor SAHA induces HSP60 nitration and its extracellular release by exosomal vesicles in human lung-derived carcinoma cells |
https://doi.org/10.18632/oncotarget.6680
Claudia Campanella,
Antonella D'Anneo,
Antonella Marino Gammazza,
Celeste Caruso Bavisotto,
Rosario Barone,
Sonia Emanuele,
Filippa Lo Cascio,
Emanuele Mocciaro,
Stefano Fais,
Everly Conway De Macario,
Alberto J.L. Macario,
Francesco Cappello,
and Marianna Lauricella
|
28849-28867 |
Heme oxygenase-1 nuclear translocation regulates bortezomib-induced cytotoxicity and mediates genomic instability in myeloma cells
Heme oxygenase-1 nuclear translocation regulates bortezomib-induced cytotoxicity and mediates genomic instability in myeloma cells |
https://doi.org/10.18632/oncotarget.7563
Daniele Tibullo,
Ignazio Barbagallo,
Cesarina Giallongo,
Luca Vanella,
Concetta Conticello,
Alessandra Romano,
Salvatore Saccone,
Justyna Godos,
Francesco Di Raimondo,
and Giovanni Li Volti
|
28868-28880 |
Betacellulin induces Slug-mediated down-regulation of E-cadherin and cell migration in ovarian cancer cells
Betacellulin induces Slug-mediated down-regulation of E-cadherin and cell migration in ovarian cancer cells |
https://doi.org/10.18632/oncotarget.7591
Jianfang Zhao,
Christian Klausen,
Xin Qiu,
Jung-Chien Cheng,
Hsun-Ming Chang,
and Peter C.K. Leung
|
28881-28890 |
Brachyury as a potential modulator of androgen receptor activity and a key player in therapy resistance in prostate cancer
Brachyury as a potential modulator of androgen receptor activity and a key player in therapy resistance in prostate cancer |
https://doi.org/10.18632/oncotarget.8499
Filipe Pinto,
Nelma Pértega-Gomes,
José R. Vizcaíno,
Raquel P. Andrade,
Flavio M. Cárcano,
and Rui Manuel Reis
|
28891-28902 |
Increased liver carcinogenesis and enrichment of stem cell properties in livers of Dickkopf 2 (Dkk2) deleted mice
Increased liver carcinogenesis and enrichment of stem cell properties in livers of Dickkopf 2 (Dkk2) deleted mice |
https://doi.org/10.18632/oncotarget.3293
Thorsten Maass,
Jens Marquardt,
Ju-Seog Lee,
Markus Krupp,
Peter Scholz-Kreisel,
Carolin Mogler,
Peter Schirmacher,
Martina Müller,
Heiner Westphal,
Peter R. Galle,
and Andreas Teufel
|
28903-28913 |
Mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia: a report from the Italian AIEOP study group
Mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia: a report from the Italian AIEOP study group |
https://doi.org/10.18632/oncotarget.8016
Silvia Bresolin,
Paola De Filippi,
Francesca Vendemini,
Mirko D’Alia,
Marco Zecca,
Lueder H. Meyer,
Cesare Danesino,
Franco Locatelli,
Riccardo Masetti,
Giuseppe Basso,
and Geertruy te Kronnie
|
28914-28919 |
Integrative transcriptome analysis identifies deregulated microRNA-transcription factor networks in lung adenocarcinoma
Integrative transcriptome analysis identifies deregulated microRNA-transcription factor networks in lung adenocarcinoma |
https://doi.org/10.18632/oncotarget.8713
Naiara C. Cinegaglia,
Sonia Cristina S. Andrade,
Tomas Tokar,
Maísa Pinheiro,
Fábio E. Severino,
Rogério A. Oliveira,
Erica N. Hasimoto,
Daniele C. Cataneo,
Antônio J.M. Cataneo,
Júlio Defaveri,
Cristiano P. Souza,
Márcia M.C. Marques,
Robson F. Carvalho,
Luiz L. Coutinho,
Jefferson L. Gross,
Silvia R. Rogatto,
Wan L. Lam,
Igor Jurisica,
and Patricia P. Reis
|
28920-28934 |
Cinobufagin inhibits tumor growth by inducing intrinsic apoptosis through AKT signaling pathway in human nonsmall cell lung cancer cells
Cinobufagin inhibits tumor growth by inducing intrinsic apoptosis through AKT signaling pathway in human nonsmall cell lung cancer cells |
https://doi.org/10.18632/oncotarget.7898
Guangxin Zhang,
Chao Wang,
Mei Sun,
Jindong Li,
Bin Wang,
Chengyan Jin,
Peiyan Hua,
Ge Song,
Yifan Zhang,
Lisa L.H. Nguyen,
Ranji Cui,
Runhua Liu,
Lizhong Wang,
and Xingyi Zhang
|
28935-28946 |
Western diet enhances benzo(a)pyrene-induced colon tumorigenesis in a polyposis in rat coli (PIRC) rat model of colon cancer
Western diet enhances benzo(a)pyrene-induced colon tumorigenesis in a polyposis in rat coli (PIRC) rat model of colon cancer |
https://doi.org/10.18632/oncotarget.7901
Kelly L. Harris,
Stephanie R. Pulliam,
Emmanuel Okoro,
Zhongmao Guo,
Mary K. Washington,
Samuel E. Adunyah,
James M. Amos-Landgraf,
and Aramandla Ramesh
|
28947-28960 |
Primary versus castration-resistant prostate cancer: modeling through novel murine prostate cancer cell lines
Primary versus castration-resistant prostate cancer: modeling through novel murine prostate cancer cell lines |
https://doi.org/10.18632/oncotarget.8436
Georges Daoud,
Alissar Monzer,
Hisham Bahmad,
Farah Chamaa,
Layal Hamdar,
Tarek H. Mouhieddine,
Sami Shayya,
Assaad Eid,
Firas Kobeissy,
Yen‑Nien Liu,
and Wassim Abou‑Kheir
|
28961-28975 |
Functional genomics screen identifies YAP1 as a key determinant to enhance treatment sensitivity in lung cancer cells
Functional genomics screen identifies YAP1 as a key determinant to enhance treatment sensitivity in lung cancer cells |
https://doi.org/10.18632/oncotarget.6721
Haiying Cheng,
Zhenfeng Zhang,
Ruth Rodriguez-Barrueco,
Alain Borczuk,
Huijie Liu,
Jiyang Yu,
Jose M. Silva,
Simon K. Cheng,
Roman Perez-Soler,
and Balazs Halmos
|
28976-28988 |
shRNA targeting long non-coding RNA CCAT2 controlled by tetracycline-inducible system inhibits progression of bladder cancer cells
shRNA targeting long non-coding RNA CCAT2 controlled by tetracycline-inducible system inhibits progression of bladder cancer cells |
https://doi.org/10.18632/oncotarget.8259
Jianfa Li,
Chengle Zhuang,
Yuchen Liu,
Mingwei Chen,
Qing Zhou,
Zhicong Chen,
Anbang He,
Guoping Zhao,
Yinglu Guo,
Hanwei Wu,
Zhiming Cai,
and Weiren Huang
|
28989-28997 |
Autophagy-related cell death by pan-histone deacetylase inhibition in liver cancer
Autophagy-related cell death by pan-histone deacetylase inhibition in liver cancer |
https://doi.org/10.18632/oncotarget.8585
Pietro Di Fazio,
Petra Waldegger,
Samir Jabari,
Susanne Lingelbach,
Roberta Montalbano,
Matthias Ocker,
Emily P. Slater,
Detlef K. Bartsch,
Romana Illig,
Daniel Neureiter,
and Thaddeus T. Wissniowski
|
28998-29010 |
Brigatinib, an anaplastic lymphoma kinase inhibitor, abrogates activity and growth in ALK-positive neuroblastoma cells, Drosophila and mice
Brigatinib, an anaplastic lymphoma kinase inhibitor, abrogates activity and growth in ALK-positive neuroblastoma cells, Drosophila and mice |
https://doi.org/10.18632/oncotarget.8508
Joachim T. Siaw,
Haiying Wan,
Kathrin Pfeifer,
Victor M. Rivera,
Jikui Guan,
Ruth H. Palmer,
and Bengt Hallberg
|
29011-29022 |
LOX is a novel mitotic spindle-associated protein essential for mitosis
LOX is a novel mitotic spindle-associated protein essential for mitosis |
https://doi.org/10.18632/oncotarget.8628
Myriem Boufraqech,
Darmood Wei,
Urbain Weyemi,
Lisa Zhang,
Martha Quezado,
Petr Kalab,
and Electron Kebebew
|
29023-29035 |
Chemotherapy-induced uridine diphosphate release promotes breast cancer metastasis through P2Y6 activation
Chemotherapy-induced uridine diphosphate release promotes breast cancer metastasis through P2Y6 activation |
https://doi.org/10.18632/oncotarget.8664
Xiaobin Ma,
Xinhua Pan,
Yinglei Wei,
Binhe Tan,
Linli Yang,
Hua Ren,
Min Qian,
and Bing Du
|
29036-29050 |
CD133+ cancer stem-like cells promote migration and invasion of salivary adenoid cystic carcinoma by inducing vasculogenic mimicry formation
CD133+ cancer stem-like cells promote migration and invasion of salivary adenoid cystic carcinoma by inducing vasculogenic mimicry formation |
https://doi.org/10.18632/oncotarget.8665
Sha-sha Wang,
Xiao-lei Gao,
Xin Liu,
Shi-yu Gao,
Yun-long Fan,
Ya-ping Jiang,
Xiang-rui Ma,
Jian Jiang,
Hao Feng,
Qian-ming Chen,
Ya-jie Tang,
Ya-ling Tang,
and Xin-hua Liang
|
29051-29062 |
Targeting of short TRPM8 isoforms induces 4TM-TRPM8-dependent apoptosis in prostate cancer cells
Targeting of short TRPM8 isoforms induces 4TM-TRPM8-dependent apoptosis in prostate cancer cells |
https://doi.org/10.18632/oncotarget.8666
Gabriel Bidaux,
Anne-Sophie Borowiec,
Charlotte Dubois,
Philippe Delcourt,
Céline Schulz,
Fabien Vanden Abeele,
Gilbert Lepage,
Emilie Desruelles,
Alexandre Bokhobza,
Etienne Dewailly,
Christian Slomianny,
Morad Roudbaraki,
Laurent Héliot,
Jean-Louis Bonnal,
Brigitte Mauroy,
Pascal Mariot,
Loïc Lemonnier,
and Natalia Prevarskaya
|
29063-29080 |
SOCS-1 rescues IL-1β-mediated suppression of epithelial sodium channel in mouse lung epithelial cells via ASK-1
SOCS-1 rescues IL-1β-mediated suppression of epithelial sodium channel in mouse lung epithelial cells via ASK-1 |
https://doi.org/10.18632/oncotarget.8543
Lakshmi Galam,
Ramani Soundararajan,
Mason Breitzig,
Ashna Rajan,
Rajashekar Reddy Yeruva,
Alexander Czachor,
Francine Harris,
Richard F. Lockey,
and Narasaiah Kolliputi
|
29081-29091 |
Efficacy of combined gemcitabine, oxaliplatin and pegaspargase (P-gemox regimen) in patients with newly diagnosed advanced-stage or relapsed/refractory extranodal NK/T-cell lymphoma
Efficacy of combined gemcitabine, oxaliplatin and pegaspargase (P-gemox regimen) in patients with newly diagnosed advanced-stage or relapsed/refractory extranodal NK/T-cell lymphoma |
https://doi.org/10.18632/oncotarget.8647
Jing-hua Wang,
Liang Wang,
Cheng-cheng Liu,
Zhong-jun Xia,
Hui-qiang Huang,
Tong-yu Lin,
Wen-qi Jiang,
and Yue Lu
|
29092-29101 |
Therapeutic potential and functional interaction of carfilzomib and vorinostat in T-cell leukemia/lymphoma
Therapeutic potential and functional interaction of carfilzomib and vorinostat in T-cell leukemia/lymphoma |
https://doi.org/10.18632/oncotarget.8667
Minjie Gao,
Gege Chen,
Houcai Wang,
Bingqian Xie,
Liangning Hu,
Yuanyuan Kong,
Guang Yang,
Yi Tao,
Ying Han,
Xiaosong Wu,
Yiwen Zhang,
Bojie Dai,
and Jumei Shi
|
29102-29115 |
Magnolol and honokiol exert a synergistic anti-tumor effect through autophagy and apoptosis in human glioblastomas
Magnolol and honokiol exert a synergistic anti-tumor effect through autophagy and apoptosis in human glioblastomas |
https://doi.org/10.18632/oncotarget.8674
Yu-Chen Cheng,
Dueng-Yuan Hueng,
Hua-Yin Huang,
Jang-Yi Chen,
and Ying Chen
|
29116-29130 |
Dual inhibition of AKT/FLT3-ITD by A674563 overcomes FLT3 ligand-induced drug resistance in FLT3-ITD positive AML
Dual inhibition of AKT/FLT3-ITD by A674563 overcomes FLT3 ligand-induced drug resistance in FLT3-ITD positive AML |
https://doi.org/10.18632/oncotarget.8675
Aoli Wang,
Hong Wu,
Cheng Chen,
Chen Hu,
Ziping Qi,
Wenchao Wang,
Kailin Yu,
Xiaochuan Liu,
Fengming Zou,
Zheng Zhao,
Jiaxin Wu,
Juan Liu,
Feiyang Liu,
Li Wang,
Richard M. Stone,
Ilene A. Galinksy,
James D. Griffin,
Shanchun Zhang,
Ellen L. Weisberg,
Jing Liu,
and Qingsong Liu
|
29131-29142 |
Protective effects of alpha lipoic acid on radiation-induced salivary gland injury in rats
Protective effects of alpha lipoic acid on radiation-induced salivary gland injury in rats |
https://doi.org/10.18632/oncotarget.8661
Jin Hyun Kim,
Kyung Mi Kim,
Myeong Hee Jung,
Jung Hwa Jung,
Ki Mun Kang,
Bae Kwon Jeong,
Jin Pyeong Kim,
Jung Je Park,
and Seung Hoon Woo
|
29143-29153 |
Circulating cell-free DNA has a high degree of specificity to detect exon 19 deletions and the single-point substitution mutation L858R in non-small cell lung cancer
Circulating cell-free DNA has a high degree of specificity to detect exon 19 deletions and the single-point substitution mutation L858R in non-small cell lung cancer |
https://doi.org/10.18632/oncotarget.8684
Xin Qian,
Jia Liu,
Yuhui Sun,
Meifang Wang,
Huaiding Lei,
Guoshi Luo,
Xianjun Liu,
Chang Xiong,
Dan Liu,
Jie Liu,
and Yijun Tang
|
29154-29165 |
Mitochondrial DNA content in breast cancer: Impact on in vitro and in vivo phenotype and patient prognosis
Mitochondrial DNA content in breast cancer: Impact on in vitro and in vivo phenotype and patient prognosis |
https://doi.org/10.18632/oncotarget.8688
Marjolein J.A. Weerts,
Anieta M. Sieuwerts,
Marcel Smid,
Maxime P. Look,
John A. Foekens,
Stefan Sleijfer,
and John W.M. Martens
|
29166-29176 |
Which patients with para-aortic lymph node (LN16) metastasis will truly benefit from curative pancreaticoduodenectomy for pancreatic head cancer?
Which patients with para-aortic lymph node (LN16) metastasis will truly benefit from curative pancreaticoduodenectomy for pancreatic head cancer? |
https://doi.org/10.18632/oncotarget.8690
Chen Liu,
Yu Lu,
Guopei Luo,
He Cheng,
Meng Guo,
Zuqiang Liu,
Jin Xu,
Jiang Long,
Liang Liu,
Deliang Fu,
Quanxing Ni,
Min Li,
and Xianjun Yu
|
29177-29186 |
Acquired resistance to combination treatment through loss of synergy with MEK and PI3K inhibitors in colorectal cancer
Acquired resistance to combination treatment through loss of synergy with MEK and PI3K inhibitors in colorectal cancer |
https://doi.org/10.18632/oncotarget.8692
Bhaskar Bhattacharya,
Sarah Hong Hui Low,
Mei Ling Chong,
Dilys Chia,
King Xin Koh,
Nur Sabrina Sapari,
Stanley Kaye,
Huynh Hung,
Touati Benoukraf,
and Richie Soong
|
29187-29198 |
CRKL mediates EML4-ALK signaling and is a potential therapeutic target for ALK-rearranged lung adenocarcinoma
CRKL mediates EML4-ALK signaling and is a potential therapeutic target for ALK-rearranged lung adenocarcinoma |
https://doi.org/10.18632/oncotarget.8638
Rong An,
Yisong Wang,
Donna Voeller,
Arjan Gower,
In-Kyu Kim,
Yu-Wen Zhang,
and Giuseppe Giaccone
|
29199-29210 |
Whole exome sequencing of urachal adenocarcinoma reveals recurrent NF1 mutations
Whole exome sequencing of urachal adenocarcinoma reveals recurrent NF1 mutations |
https://doi.org/10.18632/oncotarget.8640
Harshabad Singh,
Yang Liu,
Xiuli Xiao,
Ling Lin,
Jaegil Kim,
Paul Van Hummelen,
Chin-Lee Wu,
Adam J. Bass,
and Philip J. Saylor
|
29211-29215 |
Silencing homeobox C6 inhibits colorectal cancer cell proliferation
Silencing homeobox C6 inhibits colorectal cancer cell proliferation |
https://doi.org/10.18632/oncotarget.8703
Meiling Ji,
Qingyang Feng,
Guodong He,
Liangliang Yang,
Wentao Tang,
Xinyuan Lao,
Dexiang Zhu,
Qi Lin,
Pingping Xu,
Ye Wei,
and Jianmin Xu
|
29216-29227 |
s-SHIP expression identifies a subset of murine basal prostate cells as neonatal stem cells
s-SHIP expression identifies a subset of murine basal prostate cells as neonatal stem cells |
https://doi.org/10.18632/oncotarget.8709
Guillaume Brocqueville,
Renee S. Chmelar,
Hélène Bauderlique-Le Roy,
Emeric Deruy,
Lu Tian,
Robert L. Vessella,
Norman M. Greenberg,
Larry R. Rohrschneider,
and Roland P. Bourette
|
29228-29244 |
Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cells
Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cells |
https://doi.org/10.18632/oncotarget.8588
Xinpei Yu,
Junkui Ai,
Liquan Cai,
Yifeng Jing,
Dan Wang,
Jun Dong,
Laura E. Pascal,
Jian Zhang,
Rongcheng Luo,
and Zhou Wang
|
29245-29254 |
SIRT1 facilitates hepatocellular carcinoma metastasis by promoting PGC-1α-mediated mitochondrial biogenesis
SIRT1 facilitates hepatocellular carcinoma metastasis by promoting PGC-1α-mediated mitochondrial biogenesis |
https://doi.org/10.18632/oncotarget.8711
Yuming Li,
Shangcheng Xu,
Jing Li,
Lu Zheng,
Min Feng,
Xiaoya Wang,
Keqiang Han,
Huifeng Pi,
Min Li,
Xiaobing Huang,
Nan You,
Yewang Tian,
Guohua Zuo,
Hongyan Li,
Hongzhi Zhao,
Ping Deng,
Zhengping Yu,
Zhou Zhou,
and Ping Liang
|
29255-29274 |
MiR-320a inhibits gastric carcinoma by targeting activity in the FoxM1-P27KIP1 axis
MiR-320a inhibits gastric carcinoma by targeting activity in the FoxM1-P27KIP1 axis |
https://doi.org/10.18632/oncotarget.8676
Yangyang Wang,
Jiping Zeng,
Jianyong Pan,
Xue Geng,
Lupeng Li,
Jing Wu,
Ping Song,
Ying Wang,
Jilan Liu,
and Lixiang Wang
|
29275-29286 |
Comparative proteomics of exosomes secreted by tumoral Jurkat T cells and normal human T cell blasts unravels a potential tumorigenic role for valosin-containing protein
Comparative proteomics of exosomes secreted by tumoral Jurkat T cells and normal human T cell blasts unravels a potential tumorigenic role for valosin-containing protein |
https://doi.org/10.18632/oncotarget.8678
Alberto Bosque,
Lisa Dietz,
Ana Gallego-Lleyda,
Manuel Sanclemente,
María Iturralde,
Javier Naval,
María Angeles Alava,
Luis Martínez-Lostao,
Hermann-Josef Thierse,
and Alberto Anel
|
29287-29305 |
Nuclear factor one B (NFIB) encodes a subtype-specific tumour suppressor in glioblastoma
Nuclear factor one B (NFIB) encodes a subtype-specific tumour suppressor in glioblastoma |
https://doi.org/10.18632/oncotarget.8720
Brett W. Stringer,
Jens Bunt,
Bryan W. Day,
Guy Barry,
Paul R. Jamieson,
Kathleen S. Ensbey,
Zara C. Bruce,
Kate Goasdoué,
Hélène Vidal,
Sara Charmsaz,
Fiona M. Smith,
Leanne T. Cooper,
Michael Piper,
Andrew W. Boyd,
and Linda J. Richards
|
29306-29320 |
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer?
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer? |
https://doi.org/10.18632/oncotarget.8722
Daniele Fanale,
Valeria Amodeo,
Viviana Bazan,
Lavinia Insalaco,
Lorena Incorvaia,
Nadia Barraco,
Marta Castiglia,
Sergio Rizzo,
Daniele Santini,
Antonio Giordano,
Sergio Castorina,
and Antonio Russo
|
29321-29332 |
Reduced expression of CD109 in tumor-associated endothelial cells promotes tumor progression by paracrine interleukin-8 in hepatocellular carcinoma
Reduced expression of CD109 in tumor-associated endothelial cells promotes tumor progression by paracrine interleukin-8 in hepatocellular carcinoma |
https://doi.org/10.18632/oncotarget.8787
Bo-Gen Ye,
Hui-Chuan Sun,
Xiao-Dong Zhu,
Zong-Tao Chai,
Yuan-Yuan Zhang,
Jian-Yang Ao,
Hao Cai,
De-Ning Ma,
Cheng-Hao Wang,
Cheng-Dong Qin,
Dong-Mei Gao,
and Zhao-You Tang
|
29333-29345 |
GP73-regulated oncolytic adenoviruses possess potent killing effect on human liver cancer stem-like cells
GP73-regulated oncolytic adenoviruses possess potent killing effect on human liver cancer stem-like cells |
https://doi.org/10.18632/oncotarget.8830
Xinmin Zhang,
Shulin Meng,
Rong Zhang,
Buyun Ma,
Tao Liu,
Yu Yang,
Wenjie Xie,
Xianglei Liu,
Fang Huang,
Tao Liu,
Xiumei Zhou,
Xinyuan Liu,
and Yigang Wang
|
29346-29358 |
Wip1 suppresses ovarian cancer metastasis through the ATM/AKT/Snail mediated signaling
Wip1 suppresses ovarian cancer metastasis through the ATM/AKT/Snail mediated signaling |
https://doi.org/10.18632/oncotarget.8833
Sheng Yin,
Pan Wang,
Lina Yang,
Yang Liu,
Yan Wang,
Mingming Liu,
Zihao Qi,
Jiao Meng,
Ting-Yan Shi,
Gong Yang,
and Rongyu Zang
|
29359-29370 |
Sox9 confers stemness properties in hepatocellular carcinoma through Frizzled-7 mediated Wnt/β-catenin signaling
Sox9 confers stemness properties in hepatocellular carcinoma through Frizzled-7 mediated Wnt/β-catenin signaling |
https://doi.org/10.18632/oncotarget.8835
Carmen Oi-Ning Leung,
Wing-Nga Mak,
Alan Ka-Lun Kai,
Kwan-Shuen Chan,
Terence Kin-Wah Lee,
Irene Oi-Lin Ng,
and Regina Cheuk-Lam Lo
|
29371-29386 |
JMJD3 promotes survival of diffuse large B-cell lymphoma subtypes via distinct mechanisms
JMJD3 promotes survival of diffuse large B-cell lymphoma subtypes via distinct mechanisms |
https://doi.org/10.18632/oncotarget.8836
Yan Zhang,
Long Shen,
Dwayne G. Stupack,
Nan Bai,
Jing Xun,
Guosheng Ren,
Jihong Han,
Luyuan Li,
Yunping Luo,
Rong Xiang,
and Xiaoyue Tan
|
29387-29399 |
Anti-miR delivery strategies to bypass the blood-brain barrier in glioblastoma therapy
Anti-miR delivery strategies to bypass the blood-brain barrier in glioblastoma therapy |
https://doi.org/10.18632/oncotarget.8837
Dong Geon Kim,
Kang Ho Kim,
Yun Jee Seo,
Heekyoung Yang,
Eric G. Marcusson,
Eunju Son,
Kyoungmin Lee,
Jason K. Sa,
Hye Won Lee,
and Do-Hyun Nam
|
29400-29411 |
The role of histological subtype in hormone receptor positive metastatic breast cancer: similar survival but different therapeutic approaches
The role of histological subtype in hormone receptor positive metastatic breast cancer: similar survival but different therapeutic approaches |
https://doi.org/10.18632/oncotarget.8838
Dorien Lobbezoo,
Wilfred Truin,
Adri Voogd,
Rudi Roumen,
Gerard Vreugdenhil,
Marcus Wouter Dercksen,
Franchette van den Berkmortel,
Tineke Smilde,
Agnes van de Wouw,
Roel van Kampen,
Johanna van Riel,
Natascha Peters,
Petronella Peer,
and Vivianne C.G. Tjan-Heijnen
|
29412-29419 |
Lymph node ratio may predict the benefit of postoperative radiotherapy in node-positive cervical cancer
Lymph node ratio may predict the benefit of postoperative radiotherapy in node-positive cervical cancer |
https://doi.org/10.18632/oncotarget.8840
Juan Zhou,
Qiong-Hua Chen,
San-Gang Wu,
Zhen-Yu He,
Jia-Yuan Sun,
Feng-Yan Li,
Huan-Xin Lin,
and Ke-Li You
|
29420-29428 |
Pinin facilitated proliferation and metastasis of colorectal cancer through activating EGFR/ERK signaling pathway
Pinin facilitated proliferation and metastasis of colorectal cancer through activating EGFR/ERK signaling pathway |
https://doi.org/10.18632/oncotarget.8738
Zhigang Wei,
Wenhui Ma,
Xiaolong Qi,
Xianjun Zhu,
Yutian Wang,
Zhuoluo Xu,
Jun Luo,
Da Wang,
Weihong Guo,
Xiaomei Li,
Sainan Xin,
Jiang Yu,
and Guoxin Li
|
29429-29439 |
The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer
The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer |
https://doi.org/10.18632/oncotarget.8751
Guifang Du,
Yanan Gu,
Chengcheng Hao,
Zhu Yuan,
Junqi He,
Wen G. Jiang,
and Shan Cheng
|
29440-29453 |
NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer
NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer |
https://doi.org/10.18632/oncotarget.8762
Yan Lin,
Changchun Ma,
Chengkang Liu,
Zhening Wang,
Jurong Yang,
Xinmu Liu,
Zhiwei Shen,
and Renhua Wu
|
29454-29464 |
Human growth hormone and human prolactin function as autocrine/paracrine promoters of progression of hepatocellular carcinoma
Human growth hormone and human prolactin function as autocrine/paracrine promoters of progression of hepatocellular carcinoma |
https://doi.org/10.18632/oncotarget.8781
Xiangjun Kong,
Wenyong Wu,
Yan Yuan,
Vijay Pandey,
Zhengsheng Wu,
Xuefei Lu,
Weijie Zhang,
Yijun Chen,
Mingming Wu,
Min Zhang,
Gaopeng Li,
Sheng Tan,
Pengxu Qian,
Jo K. Perry,
Peter E. Lobie,
and Tao Zhu
|
29465-29479 |
B7-H3 as a promising target for cytotoxicity T cell in human cancer therapy
B7-H3 as a promising target for cytotoxicity T cell in human cancer therapy |
https://doi.org/10.18632/oncotarget.8784
Juan Ma,
Pan Ma,
Chenghai Zhao,
Xin Xue,
Huamin Han,
Changzhen Liu,
Hua Tao,
Weigang Xiu,
Jia Cai,
and Man Zhang
|
29480-29491 |
Inhibition of pro-HGF activation by SRI31215, a novel approach to block oncogenic HGF/MET signaling
Inhibition of pro-HGF activation by SRI31215, a novel approach to block oncogenic HGF/MET signaling |
https://doi.org/10.18632/oncotarget.8785
Benjamin Y. Owusu,
Namita Bansal,
Phanindra K.M. Venukadasula,
Larry J. Ross,
Troy E. Messick,
Sanjay Goel,
Robert A. Galemmo,
and Lidija Klampfer
|
29492-29506 |
Knockdown of CMTM3 promotes metastasis of gastric cancer via the STAT3/Twist1/EMT signaling pathway
Knockdown of CMTM3 promotes metastasis of gastric cancer via the STAT3/Twist1/EMT signaling pathway |
https://doi.org/10.18632/oncotarget.8789
Wanqiong Yuan,
Ting Li,
Xiaoning Mo,
Xiaolin Wang,
Baocai Liu,
Wenyan Wang,
Yu Su,
Lan Xu,
and Wenling Han
|
29507-29519 |
Targeting of Chk2 as a countermeasure to dose-limiting toxicity triggered by topoisomerase-II (TOP2) poisons
Targeting of Chk2 as a countermeasure to dose-limiting toxicity triggered by topoisomerase-II (TOP2) poisons |
https://doi.org/10.18632/oncotarget.8790
Prashanth Gokare,
Arunasalam Navaraj,
Shengliang Zhang,
Noboru Motoyama,
Shen-Shu Sung,
and Niklas K. Finnberg
|
29520-29530 |
Deciphering the role of nuclear and cytoplasmic IKKα in skin cancer
Deciphering the role of nuclear and cytoplasmic IKKα in skin cancer |
https://doi.org/10.18632/oncotarget.8792
Josefa P. Alameda,
Miriam Gaspar,
Ángel Ramírez,
Manuel Navarro,
Angustias Page,
Cristian Suárez-Cabrera,
Guadalupe M. Fernández,
Jose R. Mérida,
Jesús M. Paramio,
Rosa A. García-Fernández,
Jesús M. Fernández- Aceñero,
and Llanos M. Casanova
|
29531-29547 |
Hypoxia promotes Rab5 activation, leading to tumor cell migration, invasion and metastasis
Hypoxia promotes Rab5 activation, leading to tumor cell migration, invasion and metastasis |
https://doi.org/10.18632/oncotarget.8794
Patricio Silva,
Pablo Mendoza,
Solange Rivas,
Jorge Díaz,
Carolina Moraga,
Andrew F.G. Quest,
and Vicente A. Torres
|
29548-29562 |
Benzyl butyl phthalate promotes breast cancer stem cell expansion via SPHK1/S1P/S1PR3 signaling
Benzyl butyl phthalate promotes breast cancer stem cell expansion via SPHK1/S1P/S1PR3 signaling |
https://doi.org/10.18632/oncotarget.9007
Yu-Chih Wang,
Cheng-Fang Tsai,
Hsiao-Li Chuang,
Yi-Chih Chang,
Hung-Sheng Chen,
Jau-Nan Lee,
and Eing-Mei Tsai
|
29563-29576 |
Synergistic antitumor effects of combination PI3K/mTOR and MEK inhibition (SAR245409 and pimasertib) in mucinous ovarian carcinoma cells by fluorescence resonance energy transfer imaging
Synergistic antitumor effects of combination PI3K/mTOR and MEK inhibition (SAR245409 and pimasertib) in mucinous ovarian carcinoma cells by fluorescence resonance energy transfer imaging |
https://doi.org/10.18632/oncotarget.8807
Kanako Inaba,
Katsutoshi Oda,
Kazuhiro Aoki,
Kenbun Sone,
Yuji Ikeda,
Aki Miyasaka,
Tomoko Kashiyama,
Tomohiko Fukuda,
Chinami Makii,
Takahide Arimoto,
Osamu Wada-Hiraike,
Kei Kawana,
Tetsu Yano,
Yutaka Osuga,
and Tomoyuki Fujii
|
29577-29591 |
Ninjurin1 inhibits colitis-mediated colon cancer development and growth by suppression of macrophage infiltration through repression of FAK signaling
Ninjurin1 inhibits colitis-mediated colon cancer development and growth by suppression of macrophage infiltration through repression of FAK signaling |
https://doi.org/10.18632/oncotarget.9020
Jong Kyu Woo,
Yeong-Su Jang,
Ju-Hee Kang,
Jong-Ik Hwang,
Je Kyung Seong,
Sang-Jin Lee,
Sejin Jeon,
Goo Taeg Oh,
Ho-Young Lee,
and Seung Hyun Oh
|
29592-29604 |
Downregulation of amplified in breast cancer 1 contributes to the anti-tumor effects of sorafenib on human hepatocellular carcinoma
Downregulation of amplified in breast cancer 1 contributes to the anti-tumor effects of sorafenib on human hepatocellular carcinoma |
https://doi.org/10.18632/oncotarget.8812
Ming Li,
Wei Wang,
Yuzhen Dan,
Zhangwei Tong,
Wenbo Chen,
Liping Qin,
Kun Liu,
Wengang Li,
Pingli Mo,
and Chundong Yu
|
29605-29619 |
TREM-2 serves as a negative immune regulator through Syk pathway in an IL-10 dependent manner in lung cancer
TREM-2 serves as a negative immune regulator through Syk pathway in an IL-10 dependent manner in lung cancer |
https://doi.org/10.18632/oncotarget.8813
Yinan Yao,
Hequan Li,
Junjun Chen,
Weiyi Xu,
Guangdie Yang,
Zhang Bao,
Dajing Xia,
Guohua Lu,
Shuwen Hu,
and Jianying Zhou
|
29620-29634 |
Colorectal cancer cells display chaperone dependency for the unconventional prefoldin URI1
Colorectal cancer cells display chaperone dependency for the unconventional prefoldin URI1 |
https://doi.org/10.18632/oncotarget.8816
Kamil Andrzej Lipinski,
Christian Britschgi,
Karen Schrader,
Yann Christinat,
Lukas Frischknecht,
and Wilhelm Krek
|
29635-29647 |
X66, a novel N-terminal heat shock protein 90 inhibitor, exerts antitumor effects without induction of heat shock response
X66, a novel N-terminal heat shock protein 90 inhibitor, exerts antitumor effects without induction of heat shock response |
https://doi.org/10.18632/oncotarget.8818
Zhixin Zhao,
Jianming Zhu,
Haitian Quan,
Guimin Wang,
Bo Li,
Weiliang Zhu,
Chengying Xie,
and Liguang Lou
|
29648-29663 |
The La protein counteracts cisplatin-induced cell death by stimulating protein synthesis of anti-apoptotic factor Bcl2
The La protein counteracts cisplatin-induced cell death by stimulating protein synthesis of anti-apoptotic factor Bcl2 |
https://doi.org/10.18632/oncotarget.8819
Tilman Heise,
Venkatesh Kota,
Alexander Brock,
Amanda B. Morris,
Reycel M. Rodriguez,
Avery W. Zierk,
Philip H. Howe,
and Gunhild Sommer
|
29664-29676 |
Gene expression profiling of normal thyroid tissue from patients with thyroid carcinoma
Gene expression profiling of normal thyroid tissue from patients with thyroid carcinoma |
https://doi.org/10.18632/oncotarget.8820
Roberto Ria,
Vittorio Simeon,
Assunta Melaccio,
Giovanna Di Meo,
Stefania Trino,
Carmela Mazzoccoli,
Ilaria Saltarella,
Aurelia Lamanuzzi,
Annalisa Morano,
Angela Gurrado,
Alessandro Pasculli,
Gaetano Lastilla,
Pellegrino Musto,
Antonia Reale,
Franco Dammacco,
Angelo Vacca,
and Mario Testini
|
29677-29688 |
The transcription factor RUNX2 regulates receptor tyrosine kinase expression in melanoma
The transcription factor RUNX2 regulates receptor tyrosine kinase expression in melanoma |
https://doi.org/10.18632/oncotarget.8822
Rajeev K. Boregowda,
Daniel J. Medina,
Elke Markert,
Michael A. Bryan,
Wenjin Chen,
Suzie Chen,
Anna Rabkin,
Michael J. Vido,
Samuel I. Gunderson,
Marina Chekmareva,
David J. Foran,
Ahmed Lasfar,
James S. Goydos,
and Karine A. Cohen-Solal
|
29689-29707 |
Nomograms for predicting long-term survival in patients with non-metastatic nasopharyngeal carcinoma in an endemic area
Nomograms for predicting long-term survival in patients with non-metastatic nasopharyngeal carcinoma in an endemic area |
https://doi.org/10.18632/oncotarget.8823
Qi Zeng,
Ming-Huang Hong,
Lu-Jun Shen,
Xiang-Qi Meng,
Xiang Guo,
Chao-Nan Qian,
Pei-Hong Wu,
and Pei-Yu Huang
|
29708-29719 |
Relapse-related long non-coding RNA signature to improve prognosis prediction of lung adenocarcinoma
Relapse-related long non-coding RNA signature to improve prognosis prediction of lung adenocarcinoma |
https://doi.org/10.18632/oncotarget.8825
Meng Zhou,
Wanying Xu,
Xiaolong Yue,
Hengqiang Zhao,
Zhenzhen Wang,
Hongbo Shi,
Liang Cheng,
and Jie Sun
|
29720-29738 |
Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in stage III-IVb nasopharyngeal carcinoma patients with Epstein-Barr virus DNA ≥4000 copies/ml: a matched study
Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in stage III-IVb nasopharyngeal carcinoma patients with Epstein-Barr virus DNA ≥4000 copies/ml: a matched study |
https://doi.org/10.18632/oncotarget.8828
Shan-Shan Guo,
Lin-Quan Tang,
Qiu-Yan Chen,
Lu Zhang,
Li-Ting Liu,
Ling Guo,
Hao-Yuan Mo,
Dong-Hua Luo,
Pei-Yu Huang,
Yan-Qun Xiang,
Rui Sun,
Ming-Yuan Chen,
Lin Wang,
Xing Lv,
Chong Zhao,
Xiang Guo,
Ka-Jia Cao,
Chao-Nan Qian,
Mu-Shen Zeng,
Jin-Xin Bei,
Ming-Huang Hong,
Jian-Yong Shao,
Ying Sun,
Jun Ma,
and Hai-Qiang Mai
|
29739-29748 |
Suppression of epithelial-mesenchymal transition in hepatocellular carcinoma cells by Krüppel-like factor 4
Suppression of epithelial-mesenchymal transition in hepatocellular carcinoma cells by Krüppel-like factor 4 |
https://doi.org/10.18632/oncotarget.8831
Qi Li,
Weifeng Song,
Weiyu Wang,
Shanshan Yao,
Chuan Tian,
Xun Cai,
and Liwei Wang
|
29749-29760 |
Genetic changes of non-small cell lung cancer under neoadjuvant therapy
Genetic changes of non-small cell lung cancer under neoadjuvant therapy |
https://doi.org/10.18632/oncotarget.8858
Arne Warth,
Volker Endris,
Albrecht Stenzinger,
Roland Penzel,
Alexander Harms,
Thomas Duell,
Amir Abdollahi,
Michael Lindner,
Peter Schirmacher,
Thomas Muley,
Hendrik Dienemann,
Ludger Fink,
Alicia Morresi-Hauf,
Nicole Pfarr,
and Wilko Weichert
|
29761-29769 |
Two variants on T2DM susceptible gene HHEX are associated with CRC risk in a Chinese population
Two variants on T2DM susceptible gene HHEX are associated with CRC risk in a Chinese population |
https://doi.org/10.18632/oncotarget.8865
Rui Sun,
Jian-Ping Liu,
Chang Gao,
Ying-Ying Xiong,
Min Li,
Ya-Ping Wang,
Yan-Wei Su,
Mei Lin,
An-Li Jiang,
Ling-Fan Xiong,
Yan Xie,
and Jue-Ping Feng
|
29770-29779 |
Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas
Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas |
https://doi.org/10.18632/oncotarget.8957
Darío García-Carracedo,
Maria Ángeles Villaronga,
Saúl Álvarez-Teijeiro,
Francisco Hermida-Prado,
Iñigo Santamaría,
Eva Allonca,
Laura Suárez-Fernández,
Maria Victoria Gonzalez,
Milagros Balbín,
Aurora Astudillo,
Pablo Martínez-Camblor,
Gloria H. Su,
Juan Pablo Rodrigo,
and Juana María García-Pedrero
|
29780-29793 |
The effect of chemotherapy on programmed cell death 1/programmed cell death 1 ligand axis: some chemotherapeutical drugs may finally work through immune response
The effect of chemotherapy on programmed cell death 1/programmed cell death 1 ligand axis: some chemotherapeutical drugs may finally work through immune response |
https://doi.org/10.18632/oncotarget.7631
Min Luo,
and Liwu Fu
|
29794-29803 |
Notch signaling: its roles and therapeutic potential in hematological malignancies
Notch signaling: its roles and therapeutic potential in hematological malignancies |
https://doi.org/10.18632/oncotarget.7772
Yisu Gu,
Massimo Masiero,
and Alison H. Banham
|
29804-29823 |
shRNA-armed conditionally replicative adenoviruses: a promising approach for cancer therapy
shRNA-armed conditionally replicative adenoviruses: a promising approach for cancer therapy |
https://doi.org/10.18632/oncotarget.8035
Jie Zhang,
Meng Ding,
Kai Xu,
Lijun Mao,
and Junian Zheng
|
29824-29834 |
Emerging preclinical pharmacological targets for Parkinson’s disease
Emerging preclinical pharmacological targets for Parkinson’s disease |
https://doi.org/10.18632/oncotarget.8104
Sandeep Vasant More,
and Dong-Kug Choi
|
29835-29863 |
CHIP: A new modulator of human malignant disorders
CHIP: A new modulator of human malignant disorders |
https://doi.org/10.18632/oncotarget.8219
Zhe Cao,
Guanqiao Li,
Qianqian Shao,
Gang Yang,
Lianfang Zheng,
Taiping Zhang,
and Yupei Zhao
|
29864-29874 |